Jang S, Park JW, Cha HR, Jung SY, Lee JE, Jung SS, Park HS
TRIUMPH-3 (NCT05882045) is a Phase 3, 80-week, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of retatrutide once weekly compared with placebo in participants with severe obesity (Class 2 or Class 3), defined as BMI 35 kg/m 2 , and established cardiovascular disease
Wegovy belongs to a group of medicines called GLP-1 receptor agonists
MUSCLE RECOVERY 199 Our Recovery drip contains vitamins C and E, along with B complex vitamins, and amino acids such as glutamine and BCAAs, to aid in muscle recovery, reduce inflammation, and promote tissue repair
Cilastatin preconditioning attenuates renal Ischemia-reperfusion injury via hypoxia inducible factor-1 activation
FAQ What is the primary difference between Semaglutide and Tirzepatide